Search research articles
Contact Us
Filters
Showing results (821-830 of 924) with videos related to
Page
of 93
Sort By:
Brain and Behavior
|
February 28, 2017
Reproducibility of tract-based white matter microstructural measures using the ENIGMA-DTI protocol
Ashley Acheson, S Andrea Wijtenburg, Laura M Rowland, et al.
Human Brain Mapping
|
October 22, 2019
Effects of ketamine and midazolam on resting state connectivity and comparison with ENIGMA connectivity deficit patterns in schizophrenia
Bhim M Adhikari, Juergen Dukart, Joerg F Hipp, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 9, 2009
A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB)
C L Loprinzi, A C Dueck, B S Khoyratty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 2009
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426
Alex A Adjei, Sumithra J Mandrekar, Grace K Dy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 17, 2009
A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancer
J A Treat, R Gonin, M A Socinski, et al.
Leukemia & Lymphoma
|
July 7, 2007
Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51
David M Kurtz, Loren K Tschetter, Jacob B Allred, et al.
Human Brain Mapping
|
July 22, 2014
Combining diffusion tensor imaging and magnetic resonance spectroscopy to study reduced frontal white matter integrity in youths with family histories of substance use disorders
Ashley Acheson, S Andrea Wijtenburg, Laura M Rowland, et al.
Molecular Genetics and Metabolism Reports
|
March 18, 2021
Arginine to ornithine ratio as a diagnostic marker in patients with positive newborn screening for hyperargininemia
Yue Huang, Rajesh Sharma, Annette Feigenbaum, et al.
Schizophrenia Research
|
April 19, 2019
Evidence of reward system dysfunction in youth at clinical high-risk for psychosis from two event-related fMRI paradigms
Zachary B Millman, Keith Gallagher, Caroline Demro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2000
Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer
J A Bonner, J A Sloan, K M Rowland, et al.
Page
of 93
Search research articles
Search
Showing results (821-830 of 924) with videos related to
Sort By:
Page
of 93
Brain and Behavior
|
February 28, 2017
Reproducibility of tract-based white matter microstructural measures using the ENIGMA-DTI protocol
Ashley Acheson, S Andrea Wijtenburg, Laura M Rowland, et al.
Human Brain Mapping
|
October 22, 2019
Effects of ketamine and midazolam on resting state connectivity and comparison with ENIGMA connectivity deficit patterns in schizophrenia
Bhim M Adhikari, Juergen Dukart, Joerg F Hipp, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 9, 2009
A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB)
C L Loprinzi, A C Dueck, B S Khoyratty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 2009
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426
Alex A Adjei, Sumithra J Mandrekar, Grace K Dy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 17, 2009
A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancer
J A Treat, R Gonin, M A Socinski, et al.
Leukemia & Lymphoma
|
July 7, 2007
Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51
David M Kurtz, Loren K Tschetter, Jacob B Allred, et al.
Human Brain Mapping
|
July 22, 2014
Combining diffusion tensor imaging and magnetic resonance spectroscopy to study reduced frontal white matter integrity in youths with family histories of substance use disorders
Ashley Acheson, S Andrea Wijtenburg, Laura M Rowland, et al.
Molecular Genetics and Metabolism Reports
|
March 18, 2021
Arginine to ornithine ratio as a diagnostic marker in patients with positive newborn screening for hyperargininemia
Yue Huang, Rajesh Sharma, Annette Feigenbaum, et al.
Schizophrenia Research
|
April 19, 2019
Evidence of reward system dysfunction in youth at clinical high-risk for psychosis from two event-related fMRI paradigms
Zachary B Millman, Keith Gallagher, Caroline Demro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2000
Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer
J A Bonner, J A Sloan, K M Rowland, et al.
Page
of 93